Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Net Income: 2009-2024

Historic Net Income for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -$6.4 million.

  • Cumberland Pharmaceuticals' Net Income fell 26.81% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 69.22%. This contributed to the annual value of -$6.4 million for FY2024, which is 1.78% down from last year.
  • According to the latest figures from FY2024, Cumberland Pharmaceuticals' Net Income is -$6.4 million, which was down 1.78% from -$6.3 million recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Net Income registered a high of $3.2 million during FY2020, and its lowest value of -$6.4 million during FY2024.
  • For the 3-year period, Cumberland Pharmaceuticals' Net Income averaged around -$6.1 million, with its median value being -$6.3 million (2023).
  • Data for Cumberland Pharmaceuticals' Net Income shows a maximum YoY crashed of 383.31% (in 2022) over the last 5 years.
  • Cumberland Pharmaceuticals' Net Income (Yearly) stood at $3.2 million in 2020, then slumped by 37.81% to $2.0 million in 2021, then slumped by 383.31% to -$5.7 million in 2022, then dropped by 12.05% to -$6.3 million in 2023, then decreased by 1.78% to -$6.4 million in 2024.